Gland Pharma Limited (GLAND.NS) - Stock Prices, Stock Peers & Analysis

Home
GLAND.NS

Company Name	Gland Pharma Limited
Symbol	GLAND.NS
Currency	INR
Price	1,810.05
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	298,209,357,600
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1,475.05 - 2,220.95
Industry	Drug Manufacturers—General
Sector	Healthcare
CEO	Mr. Srinivas Sadu
Website	https://www.glandpharma.com

An error occurred while fetching data.

About Gland Pharma Limited

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes,